Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?
Figure 3
Opposite effect of fenretinide according to menopausal status. Cumulative hazard curves for all second breast cancers (contralateral and ipsilateral) by allocated arm, stratified by premenopausal women (a) and postmenopausal women (b).
